Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis
- Supplementary File 1:
PDF-Document (PDF, 67 KiB)
Verbenko, D.A.; Karamova, A.E.; Artamonova, O.G.; Deryabin, D.G.; Rakitko, A.; Chernitsov, A.; Krasnenko, A.; Elmuratov, A.; Solomka, V.S.; Kubanov, A.A. Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis. J. Pers. Med. 2021, 11, 20. https://doi.org/10.3390/jpm11010020
Verbenko DA, Karamova AE, Artamonova OG, Deryabin DG, Rakitko A, Chernitsov A, Krasnenko A, Elmuratov A, Solomka VS, Kubanov AA. Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis. Journal of Personalized Medicine. 2021; 11(1):20. https://doi.org/10.3390/jpm11010020
Chicago/Turabian StyleVerbenko, Dmitry A., Arfenya E. Karamova, Olga G. Artamonova, Dmitry G. Deryabin, Alexander Rakitko, Alexandr Chernitsov, Anna Krasnenko, Artem Elmuratov, Victoria S. Solomka, and Alexey A. Kubanov. 2021. "Apremilast Pharmacogenomics in Russian Patients with Moderate-to-Severe and Severe Psoriasis" Journal of Personalized Medicine 11, no. 1: 20. https://doi.org/10.3390/jpm11010020